Pembrolizumab versus ipilimumab in advanced melanoma (KEYNOTE-006): post-hoc 5-year results from an open-label, multicentre, randomised, controlled, phase 3 study
| Image |  |
|---|---|
| Description | scientific article published on 22 July 2019 |
| Author/s |
author: Georgina V. Long Paul Lorigan Jacob Schachter Bart Neyns Antoni Ribas Matteo Carlino Christian U Blank |
| Publication date | July 22, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |